Korsana Biosciences, Inc. KRSA · SEC Filings

19

Korsana Biosciences, Inc. is a clinical-stage biotechnology company developing therapies for neurode...

Price31.17

Market Cap1.42 B

Float16.19 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 12, 2026

10-K/A

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Apr 30, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 30, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 12, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

425

Form 425 - Prospectuses and communications, business combinations

Aug 25, 2026

425

Form 425 - Prospectuses and communications, business combinations

Aug 12, 2026

425

Form 425 - Prospectuses and communications, business combinations

Aug 10, 2026

425

Form 425 - Prospectuses and communications, business combinations

Aug 6, 2026

425

Form 425 - Prospectuses and communications, business combinations

Aug 3, 2026

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Jul 24, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

NEWForm S-8 - Securities to be offered to employees in employee benefit plans

Nov 9, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Jul 22, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Jul 9, 2026

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Jun 9, 2026

S-4

Form S-4 - Registration of securities, business combinations

Apr 17, 2026

S-3

SHARE RESALE REGISTRATION | Shares amount: 499,998

May 6, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A

Form DEF 14A - Other definitive proxy statements

Oct 15, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Oct 5, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2024

Ownerships

TYPE

HEADLINE

FILED AT

144

Form 144 - Report of proposed sale of securities

Oct 22, 2026

SCHEDULE 13G/A

J. WOOD CAPITAL ADVISORS LLC (Filed by)

Oct 15, 2026

SCHEDULE 13G/A

FMR LLC (Filed by)

Oct 7, 2026

144

Form 144 - Report of proposed sale of securities

Sep 23, 2026

144

Form 144 - Report of proposed sale of securities

Sep 22, 2026

SCHEDULE 13G

GENERAL ATLANTIC, L.P. (Filed by)

Sep 18, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 27, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

May 16, 2025

CORRESP

Form CORRESP - Correspondence

May 13, 2025

LETTER

Form UPLOAD - SEC-generated letter

May 12, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 13, 2025

CORRESP

Form CORRESP - Correspondence

Feb 10, 2025